Recent Posts

1. 

   What happened to allen labrune?

   What’s the real story?

   Bristol-Myers Squibb

   anonymous

   Apr 18, 2024 at 10:33 PM

2. 

   Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?

   via Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company’s acquisition of Horizon Therapeutics. For 2023, Amgen granted Bradway $22.6 million in total pay, compared with $21.4 million for...

   Pharma/Biotech Companies - In the News

   cafead

   Apr 18, 2024 at 10:22 PM

3. 

   Adstiladrin

   Non compete agreements must be signed at the time an employee is hired. They are not enforceable or legal after the start of employment.

   Ferring

   anonymous

   Apr 18, 2024 at 10:21 PM

4. 

   Worst RBM’s at ICT

   Damn. That was fast.

   Intra-Cellular Therapies

   anonymous

   Apr 18, 2024 at 10:07 PM

5. 

   Why the Pipeline Is For Making Turnaround

   Probly not. RCs chance of even an honorable mention is iffy. We need alot of grass routes support to get his reputation bulked up. Is your friend RC??

   Acorda Therapeutics

   anonymous

   Apr 18, 2024 at 10:05 PM

6. 

   DEI...cry cry cry

   You really are limited aren’t you. You have the wrong dude here if you think you would succeed against me physically or mentally. Again, DEI is for the weak souls who don’t believe in themselves and their talents/work ethic. The man who asks for...

   Genentech

   anonymous

   Apr 18, 2024 at 10:03 PM

7. 

   It's the first drug shown to slow Alzheimer's. Why is it off to a slow start? | AP News

   Spot on! Big pharma primary care strategies. Throw bodies at the market.

   Eisai

   anonymous

   Apr 18, 2024 at 9:50 PM

8. + Show More